Fennec Pharmaceuticals Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| SOUTHPOINT CAPITAL ADVISORS LP | 11/14/2024 | 4.08 M | $20.39 M | 0.00% | 14.90% |
| SONIC GP LLC | 11/14/2024 | 2.41 M | $12.04 M | 0.00% | 8.80% |
| SOLAS CAPITAL MANAGEMENT, LLC | 11/14/2024 | 1.92 M | $9.62 M | 43.55% | 7.03% |
| DG CAPITAL MANAGEMENT, LLC | 11/13/2024 | 1.52 M | $7.61 M | -6.89% | 5.56% |
| BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 1.23 M | $6.15 M | 100.00% | 4.49% |
| VANGUARD GROUP INC | 11/13/2024 | 1.05 M | $5.24 M | 2.07% | 3.83% |
| HARBERT FUND ADVISORS, INC. | 11/14/2024 | 466,869 | $2.33 M | 0.00% | 1.71% |
| STATE STREET CORP | 11/14/2024 | 328,259 | $1.64 M | 2.20% | 1.20% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 299,298 | $1.50 M | -0.76% | 1.09% |
| GENDELL JEFFREY L | 11/14/2024 | 231,841 | $1.16 M | -18.18% | 0.85% |
| LION POINT CAPITAL, LP | 11/14/2024 | 215,000 | $1.08 M | 26.47% | 0.79% |
| MORGAN STANLEY | 11/14/2024 | 148,462 | $742,310 | 45.43% | 0.54% |
| WINTON GROUP LTD | 11/12/2024 | 71,656 | $358,280 | 6.94% | 0.26% |
| RUSSELL INVESTMENTS GROUP, LTD. | 11/13/2024 | 59,817 | $299,085 | 12.21% | 0.22% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/12/2024 | 55,452 | $277,260 | 0.00% | 0.20% |
| GOLDMAN SACHS GROUP INC | 11/14/2024 | 53,753 | $268,765 | 166.98% | 0.20% |
| ADVANTAGE ALPHA CAPITAL PARTNERS LP | 11/13/2024 | 52,876 | $264,265 | 100.00% | 0.19% |
| BANK OF NEW YORK MELLON CORP | 11/12/2024 | 51,723 | $258,613 | -24.74% | 0.19% |
| HARTFORD FINANCIAL MANAGEMENT INC. | 10/28/2024 | 48,848 | $244,240 | 0.00% | 0.18% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 11/14/2024 | 48,714 | $243,570 | 3.68% | 0.18% |
| BARCLAYS PLC | 11/19/2024 | 31,319 | $157,000 | 274.27% | 0.11% |
| RHUMBLINE ADVISERS | 11/12/2024 | 30,388 | $151,940 | 4.39% | 0.11% |
| SHERBROOKE PARK ADVISERS LLC | 11/14/2024 | 29,630 | $148,150 | 4.44% | 0.11% |
| BANK OF AMERICA CORP /DE/ | 11/14/2024 | 27,124 | $135,620 | 2.59% | 0.10% |
| CIBC WORLD MARKET INC. | 11/12/2024 | 26,530 | $133,000 | -53.36% | 0.10% |
| WEXFORD CAPITAL LP | 11/14/2024 | 26,414 | $132,070 | 0.00% | 0.10% |
| NUVEEN ASSET MANAGEMENT, LLC | 11/14/2024 | 26,006 | $130,030 | 0.00% | 0.10% |
| STATE OF WISCONSIN INVESTMENT BOARD | 11/14/2024 | 24,400 | $122,000 | 87.20% | 0.09% |
| JANE STREET GROUP, LLC | 11/15/2024 | 19,339 | $96,695 | -2.35% | 0.07% |
| FRANKLIN RESOURCES INC | 11/27/2024 | 14,799 | $67,188 | 18.69% | 0.05% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2024 | 14,249 | $71,245 | -79.45% | 0.05% |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 11/14/2024 | 12,834 | $64,170 | 31.47% | 0.05% |
| COREBRIDGE FINANCIAL, INC. | 11/13/2024 | 12,533 | $62,665 | -0.61% | 0.05% |
| UBS GROUP AG | 11/14/2024 | 11,223 | $56,115 | 54.42% | 0.04% |
| VERITION FUND MANAGEMENT LLC | 11/14/2024 | 10,625 | $53,125 | -68.51% | 0.04% |
| JPMORGAN CHASE & CO | 11/08/2024 | 10,505 | $52,525 | 1.85% | 0.04% |
| 11/13/2024 | 10,000 | $50.00 M | 100.00% | 0.04% | |
| WELLS FARGO & COMPANY/MN | 11/13/2024 | 9,997 | $49,985 | 3.12% | 0.04% |
| NEW YORK STATE COMMON RETIREMENT FUND | 10/28/2024 | 9,753 | $49,000 | 0.00% | 0.04% |
| JONES FINANCIAL COMPANIES LLLP | 11/12/2024 | 5,750 | $29,900 | 784.62% | 0.02% |
| ROYAL BANK OF CANADA | 11/14/2024 | 3,028 | $15,000 | 36.95% | 0.01% |
| LEGAL & GENERAL GROUP PLC | 11/14/2024 | 2,451 | $12,267 | 0.00% | 0.01% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 11/14/2024 | 2,449 | $12,245 | -46.14% | 0.01% |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 11/14/2024 | 1,698 | $8,490 | 0.00% | 0.01% |
| STATE OF WYOMING | 11/14/2024 | 1,621 | $8,105 | -7.00% | 0.01% |
| CIBC PRIVATE WEALTH GROUP, LLC | 11/13/2024 | 1,565 | $7,825 | 0.00% | 0.01% |
| AMERITAS INVESTMENT PARTNERS, INC. | 11/13/2024 | 1,499 | $7,495 | 0.00% | 0.01% |
| LAZARD ASSET MANAGEMENT LLC | 11/14/2024 | 1,362 | $6,000 | -21.72% | 0.01% |
| FMR LLC | 11/13/2024 | 1,183 | $5,915 | 3.59% | 0.00% |
| AMALGAMATED BANK | 10/30/2024 | 612 | $3,000 | 0.00% | 0.00% |
Fennec Pharmaceuticals Inc.institutional Ownership - FAQ's
During the previous two years, 73 institutional investors and hedge funds held shares of Fennec Pharmaceuticals Inc.. The most heavily invested institutionals were:
Southpoint Capital Advisors LP: 4.08 M
Sonic GP LLC: 2.41 M
Solas Capital Management, LLC: 1.92 M
DG Capital Management, LLC: 1.52 M
BlackRock Funding, Inc. /DE: 1.23 M
VANGUARD GROUP INC: 1.05 M
54.55% of Fennec Pharmaceuticals Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 19.27 M shares in the last 24 months. This purchase volume represents approximately $119.31 M in transactions.